Abstract
Squamous cell lung carcinomas (SCC) from former employees of the Wismut uranium mining company (Saxony, Germany) were obtained from the Stollberg Archive in order to screen for p53 tumour suppressor gene codon 249 arg→met hotspot mutations, a putative molecular bio-dosimeter of alpha-particle (radon) exposure (Taylor et al (1994) Lancet: 86–87; McDonald et al (1995) Cancer Epidemiol Biomarkers Prevent 4: 791–793). Of the 29 archived samples of SCC meeting quality criteria for DNA analysis by polymerase chain reaction (PCR) and Hae III restriction enzyme digestion, two tumours were found that harboured this mutation. DNA sequencing confirmed the presence of a G to T base substitution within the Hae III site spanning codons 249 and 250 of the p53 gene that results in replacement of arginine (wild-type) by methionine at residue 249. When these data are combined with those from our previous study of tumours from the Stollberg Archive in which 50 lung tumours were examined, (including nine SCCs), we conclude that the G→T (arg→met) codon 249 mutation prevalence in the Wismut miner cohort is not sharply elevated in lung cancers in general (two mutations/79 tumours), or specifically in SCCs of the lung (two mutations/38 SCC) when compared to data from lung cancer patients with no reported occupational exposure to radon gas. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bartsch H, Hollstein M, Mustonen R, Schmidt J, Spiethoff A, Wesch H, Wiethege T and Mueller K-M (1995) Screening for putative radon-specific p53 mutation hotspot in German uranium miners. Lancet 346: 121
Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC and Montesano R (1998) IARC database of p53 gene mutations in human tumours and cell lines: updated compilation, revised formats and new visualization tools. Nucleic Acids Res 26: 205–213
Hei TK, Bedford J and Waldren CA (1994) Mutation hotspot in radon-associated lung cancer. Lancet 343: 1158
Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC (1994) Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res 22: 3551–3555
Hollstein MC, Bartsch H, Wesch H, Kure EH, Mustonen R, Muehlbauer K-R, Spiethoff A, Wegener K and Wiethege T Mueller K-M (1997) p53 gene mutation analysis in tumours of patients exposed to a-particles. Carcinogenesis 18: 511–516
Lo YMD, Darby S, Noakes L, Whitley E, Silcocks PBS, Fleming KA and Bell JI (1995) Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure. Lancet 345: 60
McDonald JW, Taylor JA, Watson MA, Saccomanno G and Devereux TR (1995) p53 and K-ras in radon-associated lung adenocarcinoma. Cancer Epidemiol Biomarkers Prevent 4: 791–793
Schuttmann W (1993) Schneeberg lung disease and uranium mining in the Saxon ore mountains (Erzgebirge). Am J Ind Med 23: 355–368
Sidransky D and Hollstein M (1996) Clinical implications of the p53 gene. Annu Rev Med 47: 285–301
Spiethoff A, Wiethege T, Hollstein M and Wesch H (1997) German uranium miners studies: evaluation of the central archive of the Institute of Pathology at Stollberg: first results. Appl Occup Environ Hyg 12: 964–969
Taylor JA, Watson MA, Devereux TR, Michels RY, Saccomanno G and Anderson M (1994) p53 mutation hotspot in radon associated lung cancer. Lancet 343: 86–87
Vahakangas K, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP and Harris CC (1992) Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339: 576–579
Venitt S and Biggs PJ (1994) Radon, mycotoxins, p53, and uranium mining. Lancet 343: 795
Wu LJ, Randers-Pehrson G, Xu A, Waldren CA, Geard CR, Yu Z and Hei TK (1999) Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci USA 96: 4959–4964
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yang, Q., Wesch, H., Mueller, KM. et al. Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation. Br J Cancer 82, 763–766 (2000). https://doi.org/10.1054/bjoc.1999.0995
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0995
Keywords
This article is cited by
-
Targeting the Akt/mTOR pathway in Brca1-deficient cancers
Oncogene (2011)